CommercialCoverageMedium impact
Charged-Particle (Proton or Helium Ion) Radiotherapy for Neoplastic Conditions
Blue Cross & Blue Shield of Mississippi·MS · Oncology, Radiation Oncology, Pediatrics +2 more·Medical Policy
We identified it
Jun 20, 2026
Summary
BCBS Mississippi updated their medical policy for charged-particle (proton or helium ion) radiotherapy, defining specific conditions where this treatment is considered medically necessary versus investigational. The policy establishes clear criteria for coverage including pediatric CNS tumors, uveal melanoma, skull-base chordomas, and certain cases where conventional radiation cannot meet dose-volume constraints.
Action Required
Immediately: Billing team must review all pending and future proton/helium ion radiotherapy claims to ensure they meet the new medical necessity criteria. Update prior authorization processes to verify conditions are covered (pediatric CNS tumors, uveal melanoma up to 24mm diameter/14mm height, skull-base chordoma/chondrosarcoma post-surgery, pediatric non-CNS tumors, non-metastatic lung cancer, head/neck cancers when photon therapy cannot meet dose constraints). Flag prostate cancer cases as investigational and likely non-covered. Coordinate with radiation oncology to obtain required dosimetry documentation showing conventional therapy limitations.